Selected Publications
Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker, JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M and Banks RE. Vascular endothelial growth factor (VEGF) in breast cancer comparison of plasma, serum and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res. 2000; 60: 2898-2905.
Banks RE, Forbes MA, Patel PM, Storr M, Hallam S, Clarke D, Novick D, Ingham E, Bowmer C, Southgate J, Trejdosiewicz LK, Illingworth J, Perren TJ and Selby PJ. Subcutaneous administration of recombinant glycosylated interleukin-6 in patients with cancer: pharmacokinetics, pharmaco-dynamics and immunomodulatory effects. Cytokine 2000; 12: 388-396.
Chester JD, Dent JT, Wilson G, Ride E and Seymour MT. Protracted Infusional 5-fluorouracil with bolus mitomycin in 5FU-resistant colorectal cancer. Ann. Oncol. 2000; 11: 235-237.
Primary Research Papers
Achuthan R, Bell SM, Leek JP, Roberts P, Horgan K, Markham AF, Selby PJ, MacLennan KA. Novel translocation of the BCL10 gene in a case of mucosa associated lymphoid tissue lymphoma. Genes Chromosomes and Cancer 2000; 29: 347-349.
Banerjee A, Seymour M. Peritoneal cytology in colorectal cancer. Diseases of the Colon and Rectum 1999; 42: 686-687.
Bani-Hani, K, Martin IG, Hardie LJ, Mapstone N, Briggs J, Forman D, Wild CP. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. Journal of the National Cancer Institute 2000; 92: 1316-1321.
Banks RE, Dunn MJ, Hochstrasser DF, Sanchez JC, Blackstock W, Pappin DJ, Selby PJ. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000; 356: 1749-1756.
Berry PA, Zhang YF, Carter ND, Jeffery S, Burchill SA. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells. Medical and Pediatric Oncology 2001; 36: 142-146.
Brewster DH, Coleman MP, Forman D, Roche M. Cancer information under threat: the case for legislation. Annals of Oncology 2001; 12: 145-147.
Bull JH, Harnden P. Efficient nuclear FISH on paraffin-embedded tissue sections using microwave pretreatment. Biotechniques 1999; 26: 416-422.
Burchill SA, Kinsey SE, Picton S, Roberts P, Pinkerton CR, Selby P, Lewis IJ. Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma. Medical and Pediatric Oncology 2001; 36: 213-219.
Burchill SA, Lewis IJ, Abrams KR, Riley R, Imeson J, Pearson ADJ, Pinkerton R, Selby P. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. Journal of Clinical Oncology 2001; 19: 1795-1801.
Coleman M. Trends in breast cancer incidence, survival, and mortality. Lancet 2000; 356: 590-591.
Crosse B, Selby PJ. Infections. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 399-419.
Davies FE, Rawstron AC, Pratt G, Coupe R, Clarke D, Lubenko A, Short K, Perren TJ, Selby PJ, MacLennan S, Major K, Woodhead V, Robinson F, Child JA, Smith GM, Johnson PWM, Morgan GJ. Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests. Hematological Oncology 2000; 18: 111-120.
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, LeBail N, Louvet C, Hendler D, deBraud F, Wilson C, Morvan F, Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology 2000; 18: 2938-2947.
Delaney B, Moayyedi P, Deeks J, Innes M, Soo S, Barton P, Wilson S, Oakes R, Harris A, Raftery J, Hobbs R, Forman D. The management of dyspepsia: a systematic review. Health Technology Assessment 2000; 4 (No 39): review.
Delaney B, Moayyedi P, Forman D. Digestive system disorders: Helicobacter pylori infection. In: Barton S (ed.) Clinical Evidence: Issue 5. London: BMJ Publishing, 2001; 324-337.
Droufakou S, Deshmane V, Roylance R, Hanby A, Tomlinson I, Hart IR. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. International Journal of Cancer 2001; 92: 404-408.
Dublin E, Hanby A, Patel NK, Liebman R, Barnes D. Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma: fibroblastic expression has strong associations with tumor pathology. American Journal of Pathology 2000; 157: 1219-1227.
Economopoulou P, Hanby A, Odell EW. Expression of E-cadherin, cellular differentiation and polarity in epithelial salivary neoplasms. Oral Oncology-European Journal of Cancer Part B 2000; 36: 515-518.
Ferguson B, Newton-Bishop J, Sculpher M. Health economic evaluation and the cost-effectiveness of malignant melanoma services. In: MacKie RM, Murray D, Rosin RD, Hancock B, Miles A (ed.) The Effective Management of Malignant Melanoma. UK Key Advances in Clinical Practice Series 2001. London: Aesculapius Medical, 2001; 143-155.
Forman D. The epidemiology of stomach cancer:correlating the past with the present. British Medical Journal 2000; 320: 1682-1683.
Forman D. Cancer survival. Lancet 2001; 357: 555
Fossa SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP, Medical Research Council Testicular Tumor Working Party. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Journal of Clinical Oncology 1999; 17: 1146-1154.
Gatter KC, MacLennan KA, Mason DY. Malignant lymphomas. In: Hoffbrand AV, Pettit JE (ed.) Color Atlas of Clinical Hematology, 3rd ed. London: Mosby, 2000; 191-232.
Gillett CE, Miles DW, Ryder K, Skilton D, Liebman RD, Springall RJ, Barnes DM, Hanby AM. Retention of the expression of E-cadherin and cetenins is associated with shorter survival in grade III ductal carcinoma of the breast. Journal of Pathology 2001; 193: 433-441.
Gillett CE, Springall RJ, Barnes DM, Hanby AM. Multiple tissue core arrays in histopathology research: a validation study. Journal of Pathology 2000; 192: 549-553.
Hamilton A, Larsimont D, Paridaens R, Drijkoningen M, van de Vijver M, Bruning P, Hanby A, Houston S, Treilleux I, Guastalla JP, Van Vreckem A, Sylvester R, Piccart M. A study of the value of p53, HER2, and Bcl-2 in the prediction of response to Doxorubicin and Paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923. Clinical Breast Cancer 2000; 1: 233-240.
Hanby AM, Kelsell DP, Potts HW, Gillett CE, Bishop DT, Spurr NK, Barnes DM. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer. International Journal of Cancer 2000; 88: 204-208.
Hancock BW, Gregory WM, Cullen MH, Hudson GV, Burton A, Selby P, Maclennan KA, Jack A, Bessell EM, Smith P, Linch DC. ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial. British Journal of Cancer 2001; 84: 1293-1300.
Hancock BW, Selby PJ. Advanced Hodgkin's disease. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 269-285.
Hancock BW, Selby PJ, Armitage JO, MacLennan KA. The way forward. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 437-438.
Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000.
Hayward RA, Forman D. The health care epidemiology of lung cancer. In: Muers MF, Macbeth F, Wells FC, Miles A (ed.) The Effective Management of Lung Cancer. London: Aesculapius Medical Press, 2001; 1-15.
Jack AS, Richards SJ, MacLennan KA. T cell lymphoproliferative disorders. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 55-69.
James RD, Seymour MT. Chemotherapy for advanced colorectal cancer. In: Scholefield JH (ed.) Challenges in Colorectal Cancer. Oxford: Blackwell Science, 2000; 166-191.
Johnson PWM, Muers MF, Peake MD, Poulter KM, Gurney EM, Napp V, Hepburn PM, Brown JM. A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer. British Journal of Cancer 2001; 84: 19-24.
Johnson PWM, Selby PJ, Hancock BW. Hodgkin's disease: clinical features. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 181-204.
Jones WG, Forman D, Harnden P. Aetiology, pathology and staging of testicular tumours. European Urology 2000; 37 (Curric Urol 6.5): 1-10.
Katzka D, Delaney B, Forman D, Moayyedi P. Digestive system disorders: gastro-oesophageal reflux disease. In: Barton S (ed.) Clinical Evidence: Issue 4. London: BMJ Publishing, 2000; 253-265.
MacLennan KA. Follicular lymphoma. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 21-26.
MacLennan KA. Lymphoma classification. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 3-8.
MacLennan KA. Diffuse indolent B cell neoplasms. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 43-47.
MacLennan KA. Diffuse agressive B cell neoplasms. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 49-54
MacLennan KA, Vaughan Hudson B, Vaughan Hudson G. Hodgkin's disease. In: Hancock BW, Selby PJ, MacLennan K, Armitage JO (ed.) Malignant Lymphoma. London: Arnold, 2000; 9-19.
Mahendran R, Newton-Bishop JA. Survey of UK current practice in the treatment of lentigo maligna. British Journal of Dermatology 2001; 144: 71-76.
Mainwaring PN, Cunningham D, Gregory W, Hoskin P, Hancock B, Norton AJ, MacLennan K, Smith P, Vaughn Hudson G, Linch D. Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood 2001; 97: 2991-2997.
Martin IG, Morris E, Forman D. Upper gastrointestinal cancer. In: Irvine EJ, Hunt RH (ed.) Evidence-Based Gastroenterology. Hamilton: BC Decker, 2001; 136-146.
Mcfarlane GA, Wyatt J, Forman D, Lachlan GW. Trends over time in Helicobacter pylori gastritis in Kenya. Journal of Gastroenterology and Hepatology 2000; 12: 617-621.
Melville A, Morris E, Forman D, Eastwood A. Management of upper gastrointestinal cancers. Quality in Health Care 2001; 10: 57-64.
Meta-Analysis Group in Cancer. Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer. British Journal of Cancer 2001; 84: 611-620 (ICRF contributors: Seymour MT).
Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M, Axon A. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. American Journal of Gastroenterology 2000; 95: 1448-1455.
Moayyedi P, Shelly S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. British Medical Journal 2000; 321: 659-664.
Newton Bishop JA, Bradburn M, Bergman W, Osterlind A, Pinney E, Rosdahl I, Scerri L, Weichenthal M, Mant D, Breitbart EW, Karlsson P, Altman DG. Teaching non-specialist healthcare professionals how to identify a atypical mole syndrome phenotype: a multinational study. British Journal of Dermatology 2000; 134: 331-337.
Parkinson MC, Harland SJ, Harnden P, Sandison A. The role of the histopathologist in the management of testicular germ cell tumour in adults. Histopathology 2001; 38: 183-194.
Perren TJ, Wilkinson N. Mucinous tumours of the ovary: primary or secondary? In: Ledermann JA, Hoskins WJ, Kaye SB, Vergote IB (ed.) Clinical Management of Ovarian Cancer. London: Dunitz, 2001; 47-66.
Plunkett TA, Hanby AM, Miles DW, Rubens RD. Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Annals of Oncology 2001; 12: 411-414.
Poole CJ, Perren T, Burton A, Jordan SD, Jenkins AH, Mould JJ, Spooner DA, Luesley D, Chan KK, Sturman S, Earl HM. Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer. Annals of Oncology 2000; 11: 1603-1608.
Protheroe AS, Pickard C, Johnson PWM, Craddock T, Shefta J, Short K, Lancaster F, Selby PJ, Henwood J, Boylston AW. Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue. British Journal of Haematology 2000; 111: 766-773.
Rowan A, Churchman M, Jeffery R, Hanby A, Poulsom R, Tomlinson I. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. Journal of Pathology 2000; 192: 203-206.
Scott J, Spencer A, MacLennan KA. Choledochoduodenal fistula complicating Non-Hodgkin's Lymphoma of the duodenum during chemotherapy. Clinical Radiology 2001; 56: 508-510.
Seymour MT. Combination chemotherapy for advanced colorectal cancer. In: Cunningham D, Haller D, Miles A (ed.) The Effective Management of Colorectal Cancer. London: Aesculapius Medical Press, 2000; 63-73.
Simnett SJ, Stewart LA, Sweetenham J, Morgan G, Johnson PWM. Autologous stem cell transplantation for malignancy: a systematic review of the literature. Clinical and Laboratory Haematology 2000; 22: 61-72.
Spencer JA, Crosse BA, Mannion RAJ, Sen KK, Perren TJ, Chapman AH. Gastroduodenal obstruction from ovarian cancer: imaging features and clinical outcome. Clinical Radiology 2000; 55: 264-272.
Sturla L-M, Westwood G, Selby PJ, Lewis IJ, Burchill SA. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma. Cancer Research 2000; 60: 6160-6170.
Todryk SM, Melcher AA, Dalgleish AG, Vile RG. Heat shock proteins refine the danger theory. Immunology 2000; 99: 334-337.
UK Consensus Statement on Standard Practice for Chemotherapy in Ovarian Cancer. ICON2 trial. Lancet 1999; 353: 587-588 (ICRF contributors: Ganesan TS, Perren TJ, Smyth JF, Thomas H).
Weisenburger DD, Anderson JR, Diebold J, Gascoyne RD, MacLennan KA, Muller-Hermelink HK, Nathwani BN, Ullrich F, Armitage JO. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. American Journal of Hematology 2001; 67: 172-178.
Willetts IE, Kite P, Barclay GR, Banks RE, Rumley A, Allgar V, Stringer MD. Endotoxin, cytokines and lipid peroxides in children with intussusception. British Journal of Surgery 2001; 88: 878-883.
